STAGE IIA BREAST CANCER

Clinical trials for STAGE IIA BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new STAGE IIA BREAST CANCER trials appear

Sign up with your email to follow new studies for STAGE IIA BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 7 Completed 5 Terminated 1

New drug cocktail aims to wipe out HER2-Low breast cancer before surgery

Disease control Recruiting now

This phase II trial is testing whether a targeted drug called trastuzumab deruxtecan (Enhertu), given alone or with anastrozole (Arimidex), can eliminate HER2-low, hormone receptor positive breast cancer before surgery. The study will enroll 88 people with early-stage breast canc…

Matched conditions: STAGE IIA BREAST CANCER

Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 07:56 UTC

STAGE IIA BREAST CANCER

Get alerted when new STAGE IIA BREAST CANCER trials appear

New drug cocktail aims to wipe out HER2-Low breast cancer before surgery